Angela Walsh
2021
In 2021, Angela Walsh earned a total compensation of $413.8K as Senior Vice President of Finance at Virios Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $48,043 |
|---|---|
| Option Awards | $150,334 |
| Salary | $213,525 |
| Other | $1,900 |
| Total | $413,802 |
Walsh received $213.5K in salary, accounting for 52% of the total pay in 2021.
Walsh also received $48K in non-equity incentive plan, $150.3K in option awards and $1.9K in other compensation.
Rankings
In 2021, Angela Walsh's compensation ranked 11,103rd out of 12,406 executives tracked by ExecPay. In other words, Walsh earned more than 10.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,103 out of 12,406 | 11th |
Division Manufacturing | 4,895 out of 5,492 | 11th |
Major group Chemicals And Allied Products | 2,183 out of 2,368 | 8th |
Industry group Drugs | 1,942 out of 2,089 | 7th |
Industry Pharmaceutical Preparations | 1,435 out of 1,536 | 7th |
Source: SEC filing on April 27, 2023.
Walsh's colleagues
We found three more compensation records of executives who worked with Angela Walsh at Virios Therapeutics in 2021.
News
Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
April 25, 2024
Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
April 27, 2023
Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
April 26, 2022
Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
April 28, 2021